Chronic GERD and risk of esophageal adenocarcinoma: Should we screen with gastroscopy?
- PMID: 32631910
- PMCID: PMC7828896
- DOI: 10.1503/cmaj.200697
Chronic GERD and risk of esophageal adenocarcinoma: Should we screen with gastroscopy?
Conflict of interest statement
Competing interests: Sander Veldhuyzen van Zanten reports receiving consulting fees from Paladin and speaker fees from Pfizer, and reports being an advisory board member for AbbVie and Allergan, all outside the submitted work.
Comment on
-
Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.CMAJ. 2020 Jul 6;192(27):E768-E777. doi: 10.1503/cmaj.190814. CMAJ. 2020. PMID: 32631908 Free PMC article. Review. No abstract available.
References
-
- Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011;140:1084–91. - PubMed
-
- Shaheen NJ, Weinberg D, Denberg T, et al. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 2012;157:808–16. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical